BIOTECH 3020 - Molecular Microbiology and Vaccines III

North Terrace Campus - Semester 2 - 2024

Recent advances in medical and microbial molecular biotechnology, have led to great strides in the understanding and treatment of human diseases. Recognising the impact of these advances on human health and economic development, scientists and industry are harnessing these enabling technologies to meet the new challenges in medical microbiology and infectious diseases. This course develops key concepts in molecular bacteriology and virology, identifying key targets for rational vaccine design, use of animal models to determine immune responses to vaccines and assessment of efficacy, development of new generation vaccines, and regulation of vaccine production and quality control.

The University of Adelaide is committed to regular reviews of the courses and programs it offers to students. The University of Adelaide therefore reserves the right to discontinue or vary programs and courses without notice. Please read the important information contained in the disclaimer.